Private Equity/Technology services, internet and consumer, healthcare
Apax Partners (India) logo

Apax Partners (India)

Buyout fund research profile

Apax has a technology-heavy India history within its global buyout platform, with Rohan Haldea overseeing Apax India and participating in the firm’s major India-linked technology transactions. The strategy is operationally oriented and concentrated in technology and tech-enabled services.

At a glance

Founded
1972
Footprint
London / Mumbai
Stage
Buyout

Research profile

Read the manager in sequence.

Open a section to inspect the evidence. The first view starts with the investment point of view; the rest stays quiet until you need it.

Investment lens

Apax Partners (India) uses a buyout approach across Technology services, internet and consumer, healthcare.

Current evidence

Apax’s current India team page names Harjot Dhaliwal as Partner and Head of India and Varunsrinivas Sridharan as a Mumbai-based Vice President who joined in 2025. Apax’s current investment pages identify India-linked positions including GlobalLogic, Fractal Analytics, Manappuram Finance and Chola, while iD Fresh Food announced a strategic investment from Apax Funds in January 2026. Healthium’s 2024 sale to KKR is retained as a verified India outcome. India-only allocation and fund-level returns remain not publicly disclosed.

Strategy

Buyout

Sector focus

Technology services, internet and consumer, healthcare

AIF structure context

Indian private equity, growth, buyout and many real-asset strategies are commonly structured as Category II AIFs. Verify the specific vehicle and registration before investing.

Current signal

Apax’s current India team page names Harjot Dhaliwal as Partner and Head of India and Varunsrinivas Sridharan as a Mumbai-based Vice President who joined in 2025. Apax’s current investment pages identify India-linked positions including GlobalLogic, Fractal Analytics, Manappuram Finance and Chola, while iD Fresh Food announced a strategic investment from Apax Funds in January 2026. Healthium’s 2024 sale to KKR is retained as a verified India outcome. India-only allocation and fund-level returns remain not publicly disclosed.

Investor questions

Apax Partners (India) research questions

What is Apax Partners (India)'s investment strategy?

Apax Partners (India) is covered in Rupeia's private equity research universe. The current public record describes the strategy as Buyout, with a sector focus of Technology services, internet and consumer, healthcare. The profile should be read with the linked source trail and Typical route: Category II AIF context.

What portfolio evidence is available for Apax Partners (India)?

The profile displays only company or asset names attributable to Apax Partners (India) in the reviewed public sources: GlobalLogic, Fractal Analytics, iD Fresh Food, Manappuram Finance, Chola, Healthium. It does not represent a complete current portfolio unless the manager has published one.

What is known about Apax Partners (India)'s performance or track record?

Apax’s GlobalLogic investment is listed as realised and its partnership page describes operational-excellence work; the firm has also backed Fractal Analytics and iD Fresh Food. India fund-level IRR and DPI are not disclosed in the reviewed record. These signals are not a substitute for fund- and vintage-specific net performance, realised distributions and audited or administrator-supported reporting.

What are Apax Partners (India)'s fund size, fees and minimum investment?

Public fund size: Apax Global Buyout XI was reported at more than $12B; no India-only vehicle size is disclosed.. Public terms or access information: Global buyout investing with India activity concentrated in technology, business services, consumer and selected healthcare. India cheque sizes and reserve policy are not consistently disclosed.. Current fees, minimum commitment and availability must be confirmed for the exact named vehicle in its fund documents.

Who is on Apax Partners (India)'s investment team?

The current source record names Harjot Dhaliwal (Partner, Head of India); Varunsrinivas Sridharan (Vice President, India team); Rohan Haldea (former India team member / prior record). Verify current roles, departures, attribution and key-person provisions before relying on the team history for a new commitment.

What risks should be reviewed before investing with Apax Partners (India)?

Review entry valuation, leverage, governance rights, concentration, execution of the value-creation plan and exit timing. The current open diligence point is: India-only fund allocation and fund-level realised performance remain not publicly disclosed; positions are disclosed at the Apax Funds/global platform level rather than through a dedicated India-only vehicle..

What is the latest public update on Apax Partners (India)?

2026-01-05: Apax’s current India team page names Harjot Dhaliwal as Partner and Head of India and Varunsrinivas Sridharan as a Mumbai-based Vice President who joined in 2025. Apax’s current investment pages identify India-linked positions including GlobalLogic, Fractal Analytics, Manappuram Finance and Chola, while iD Fresh Food announced a strategic investment from Apax Funds in January 2026. Healthium’s 2024 sale to KKR is retained as a verified India outcome. India-only allocation and fund-level returns remain not publicly disclosed.

Next step

Need this manager reviewed against your mandate?

Share the allocation question, ticket size, liquidity constraints and existing exposure. Rupeia can determine whether this profile needs a deeper decision-support brief.

Request independent diligence →